Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Published:November 14, 2016DOI:

      Background & Aims

      We performed a multicenter study to determine whether transabdominal bowel wall ultrasonography, a noninvasive procedure that does not require radiation, can be used to monitor progression of Crohn’s disease (CD).


      We performed a 12-month prospective, noninterventional study at 47 sites in Germany, from December 2010 through September 2014. Our study included 234 adult patients with CD who experienced a flare, defined as Harvey-Bradshaw index score of ≥7. All patients received treatment intensification, most with tumor necrosis factor antagonists. Ultrasound parameters and clinical data were assessed at baseline and then after 3, 6, and 12 months. The primary endpoint was the change in ultrasound parameters within 12 months of study enrollment.


      All patients included had bowel wall alterations either within the terminal ileum and/or segments of the colon. After 3 and 12 months, ultrasonographic examination showed significant improvements of nearly all ultrasound parameters, including reductions in bowel wall thickening or stratification, decreased fibrofatty proliferation, and increased signals in color Doppler ultrasound (P < .01 for all parameters at months 3 and 12). Median Harvey-Bradshaw index scores decreased from 10 at baseline to 2 after 12 months. Improvement in bowel wall thickness correlated with reduced levels of C-reactive protein after 3 months (P ≤ .001).


      In a multicenter prospective study, we found that ultrasonographic examination can be used to monitor disease activity in patients with active CD. Bowel ultrasonography seems to be an ideal follow-up method to evaluate early transmural changes in disease activity, in response to medical treatment. German Clinical Trials Register:


      Abbreviations used in this paper:

      AP (analysis population), BWT (bowel wall thickening), CD (Crohn’s disease), CRP (C-reactive protein), HBI (Harvey-Bradshaw index), US (transabdominal bowel ultrasonograhy)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Baumgart D.C.
        • Sandborn W.J.
        Crohn’s disease.
        Lancet. 2012; 380: 1590-1605
        • Schoepfer A.M.
        • Beglinger C.
        • Straumann A.
        • et al.
        Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
        Am J Gastroenterol. 2010; 105: 162-169
        • Valette P.J.
        • Rioux M.
        • Pilleul F.
        • et al.
        Ultrasonography of chronic inflammatory bowel diseases.
        Eur Radiol. 2001; 11: 1859-1866
        • Schlottmann K.
        • Kratzer W.
        • Schölmerich J.
        Doppler ultrasound and intravenous contrast agents in gastrointestinal tract disorders: current role and future implications.
        Eur J Gastroenterol Hepatol. 2005; 17: 263-275
        • Panes J.
        • Bouhnik Y.
        • Reinisch W.
        • et al.
        Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.
        J Crohns Colitis. 2013; 7: 556-585
        • Allocca M.
        • Fiorino G.
        • Danese S.
        Cross-sectional imaging modalities in Crohn's disease.
        Dig Dis. 2013; 31: 199-201
        • Parente F.
        • Greco S.
        • Molteni M.
        • et al.
        Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, X ray studies, and ileocolonoscopy.
        Gut. 2004; 53: 1652-1657
        • Ripollés T.
        • Martínez M.J.
        • Barrachina M.M.
        Crohn's disease and color Doppler sonography: response to treatment and its relationship with long-term prognosis.
        J Clin Ultrasound. 2008; 36: 267-272
        • Paredes J.M.
        • Ripollés T.
        • Cortés X.
        • et al.
        Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease.
        Dig Dis Sci. 2010; 55: 404-410
        • Van Assche G.
        • Dignass A.
        • Panes J.
        • et al.
        The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.
        J Crohn's Colitis. 2010; 4: 7-27
        • Preiss J.C.
        • Bokemeyer B.
        • Buhr H.J.
        • et al.
        Updated German clinical practice guideline on “Diagnosis and treatment of Crohn's disease.”.
        Z Gastroenterol. 2014; 52: 1431-1484
        • Schuler A.
        • Reuss J.
        • Delorme S.
        • et al.
        Costs of clinical ultrasound examinations: an economical cost calculation and analysis.
        Ultraschall Med. 2010; 31: 379-386
        • Limberg B.
        Diagnosis of chronic inflammatory bowel disease by ultrasonography.
        Z Gastroenterol. 1999; 37: 495-508
        • Harvey R.F.
        • Bradshaw J.M.
        A simple index of Crohn’s-disease activity.
        Lancet. 1980; 315: 514
        • Caprilli R.
        Why does Crohn’s disease usually occur in terminal ileum.
        J Crohn's Colitis. 2008; 2: 352-356
        • Rieder F.
        • Zimmermann E.M.
        • Remzi F.H.
        • et al.
        Crohn's disease complicated by strictures: a systematic review.
        Gut. 2013; 62: 1072-1084
        • Pariente B.
        • Cosnes J.
        • Danese S.
        • et al.
        Development of the Crohn's disease digestive damage score, the Lémann score.
        Inflamm Bowel Dis. 2011; 17: 1415-1422
        • Yaffe B.H.
        • Korelitz B.I.
        Prognosis for nonoperative management of small-bowel obstruction in Crohn's disease.
        J Clin Gastroenterol. 1983; 5: 211-215
        • Calabrese E.
        • Petruzziello C.
        • Onali S.
        • et al.
        Severity of postoperative recurrence in Crohn’s disease: correlation between endoscopic and sonographic findings.
        Inflamm Bowel Dis. 2009; 15: 1635-1642
        • Drews B.H.
        • Barth T.F.
        • Haenle M.M.
        • et al.
        Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn’s disease.
        Eur Radiol. 2009; 19: 1379-1386
        • Ricanek P.
        • Brackmann S.
        • Perminow G.
        • et al.
        Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
        Scand J Gastroenterol. 2011; 46: 1081-1091
        • Maconi G.
        • Bollani S.
        Bianchi Porro G. US detection of intestinal complications in Crohn’s disease.
        Dig Dis Sci. 1996; 41: 1643-1648
        • Gasche C.
        • Moser G.
        • Turetschek K.
        • et al.
        Transabdominal bowel sonography for detection of intestinal complication in Crohn’s disease.
        Gut. 1999; 44: 112-117